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Abstract
Objectives Up to 20 % of incidentally found testicular lesions
are benign Leydig cell tumours (LCTs). This study evaluates
the role of contrast-enhanced magnetic resonance imaging
(MRI) in the identification of LCTs in a large prospective
cohort study.
Materials and methods We enrolled 44 consecutive patients
with at least one solid non-palpable testicular lesion who
underwent scrotal MRI. Margins of the lesions, signal inten-
sity and pattern of wash-in and wash-out were analysed by
two radiologists. The frequency distribution of malignant and
benign MRI features in the different groups was compared by
using the chi-squared or Fisher’s exact test. Sensitivity, spec-
ificity, positive and negative predictive value, and diagnostic
accuracy were calculated.
Results The sensitivity of scrotal MRI to diagnose LCTs was
89.47 % with 95.65 % specificity; sensitivity for malignant
lesions was 95.65 % with 80.95 % specificity. A markedly
hypointense signal on T2-WI, rapid and marked wash-in
followed by a prolonged washout were distinctive features
significantly associated with LCTs. Malignant lesions were
significantly associated with blurred margins, weak
hypointense signal on T2-WI ,and weak and progressive
wash-in. The overall diagnostic accuracy was 93 %.
Conclusions LCTs have distinctive contrast-enhanced MRI
features that allow the differential diagnosis of incidental tes-
ticular lesions.
Key Points
• MRI is able to characterize testicular lesions suggesting a
specific diagnosis.
• Rapid and marked wash-in is a common feature of Leydig
cell tumours.
• Markedly hypointense T2-WI signal is significantly corre-
lated with benign lesions.
• Blurred margins and weak hypointense T2-WI signal are
correlated with malignant tumours.
• Weak and progressive wash-in features are present in 85 %
of seminomatous lesions.
Keywords Magnetic resonance imaging . Testicular cancer .
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Introduction
Testicular tumours account for 4–6 % of all neoplasms of the
male urogenital tract and for 1–2 % of all cancers in young
males [1]. A high proportion of small testicular lesions have
been proven benign [2, 3]. Leydig cell tumours account for up
to 22% of tumours less than 1.5 cm in size, incidentally found
during routine ultrasound (US) [2].
The ability to distinguish benign from malignant non-
palpable lesions pre-operatively allows opting for conserva-
tive surgery or follow-up in selected cases, with preservation
of fertility, endocrine function and relevant savings for health
services [4].
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Scrotal US is the preferred modality in the assessment of
male reproductive problems increasing the detection of inci-
dentally non-palpable lesions. However, it does not allow a
characterization of their nature [5, 6]. A significant improve-
ment in the diagnostic accuracy has been demonstrated by
integrating US with contrast-enhanced US (CEUS) [2, 7, 8]
and elastosonography [7, 9].
The issue is of particular relevance for monorchid patients
and those with bilateral lesions.
Magnetic resonance imaging (MRI) has been recently pro-
posed as an additional diagnostic procedure in the characteri-
zation of testicular masses, offering higher sensitivity and
specificity than unenhanced US for selected testicular pathol-
ogies [10].
The role of MRI in the differential diagnosis of testicular
masses, particularly the use of contrast agents, is still contro-
versial. Although dynamic contrast-enhanced subtraction
MRI (DCE-MRI) imaging can provide information about tes-
ticular perfusion by means of testicular contrast enhancement
[11], the clinical value and diagnostic performance of DCE-
MRI is not yet established, as was recently demonstrated with
CEUS [12].
The aim of this study was to evaluate prospectively the
accuracy of qualitative and semi-quantitative contrast-en-
hanced MRI in the differential diagnosis of non-palpable tes-
ticular masses.
Materials and methods
Patients
The local review board approved the protocol, and all patients
provided written informed consent. This was a prospective
diagnostic accuracy study, conducted at our hospital, between
2006 and June 2012.
All patients included in the CEUS diagnostic study by
Isidori et al. [2] with at least one solid, non-palpable testicular
lesion, were offered undergoing MRI imaging of the scrotum
with gadolinium enhancement. Indications for CEUS are de-
scribed in Table 1. Only patients with proven histology (ref-
erence diagnosis) were considered in the current analysis.
Subjects underwent routine blood tests, hormonal investi-
gations (LH, FSH, testosterone, inhibin B, SHBG, E2) and
tumour markers (beta-HCG, alfa-FP, CEA, LDH, PLAP),
and were scheduled to undergo scrotal MRI. Thereafter
tissue-sparing surgical enucleation was offered for histologi-
cal confirmation to all patients, independently of the CEUS
and MRI results. Malignant tumours were immediately or
subsequently treated with radical orchiectomy.
The time interval between CEUS, MRI and surgery was
less than 3 weeks. The exclusion criteria were: absence of
internal enhancement after contrast administration on MRI
and absence of histological diagnosis. None had cardiac
insufficiency.
MRI protocol
Patients did not require any preparation, except measuremnet
of serum creatinine prior to administration of intravenous me-
dium contrast. All patients were examined in the supine posi-
tion. The penis was draped to the anterior abdominal wall.
Testes were placed at a similar distance, with a towel placed
between them. All the examinations were performed on a
1.5 T system (Siemens Magnetom Avanto, Erlangen, Germa-
ny), with the use of a phased array multichannel (32 channels)
body coil. The MRI protocol included: orientation sequences:
T2-weighted (T2-W)HASTE (Half Fourier Single Shot Turbo
Spin Echo) (slice thickness (SL)=6 mm; repetition time
(TR)=1000 msec; echo time (TE)=85 msec; flip angle
(FA)=150); morphological sequences: T2-WTurbo Spin Ech-
o High resolution sequences (SL=3.00 mm; TR =3659-
5740 msec; TE=95-110 msec; FA=40-150; field of view
(FOV)=240 x 240; Matrix=256 x 224); T1-weighted (T1-
W) Flash 2D sequences (Fast low-angle single shot Gradi-
ent-Echo) with breath hold, with and without fat saturation
(SL=5.5 mm; TR=137–240 msec; TE=5 msec; FA 70; Ma-
trix=256 x 205; FOV=350 x 350); T1-WI in and out of phase
(SL=3 mm; TR=125 msec; TE=2-5 msec; FA=70; Matrix=
256 x 243; FOV=450 x 450).
A medium contrast agent (Gadobenate Dimeglumine,
Multihance Bracco 0,1 mL/kg) was administered intravenous-
ly; we applied VIBE (volumetric interpolated breath-hold ex-
amination) sequences (SL=4 mm; FA=12; FOV=280 x 280;
Matrix=256 x 224; TR=4 msec; TE=2 msec) in a dynamic
protocol acquiring a pre-contrast scan followed by a post-
contrastoghraphic series of six consecutives phases of 20 s
each. Finally we completed the study with the elaboration of
pre- and post-contrast sequences thus obtaining subtracted
images. Examination was completed with a coronal plane
scan of the abdomen in order to identify associated
Table 1 Reason for referral for scrotal ultrasound and MRI
Reason for scrotal ultrasound and MRI No. (%) of patients,
n=44 n=115
Infertility 26 (59.1)
Andrological screening/other 6 (13.6)
Testicular pain 4 (9.1)
Previous orchiectomy for
contralateral tumoura
6 (13.6)
Klinefelter syndrome 1 (2.3)
Hypogonadism 1 (2.3)
a Six patients had previous surgery of the testis for testicular tumour; this
was the first scan for the remaining 38 patients
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pathologies. The total acquisition time of the examination was
30 min.
Image analysis
Radiologists used the Sony LMD-2451 MD monitor (resolu-
tion 1220 x 1920 pixels) for the prospective reading of mass
lesion characteristics. MRI image interpretation was per-
formed by two radiologists with more than 15 years and
5 years of experience in genitourinary imaging, respectively,
blinded to the surgical or histopathological results, and dis-
crepancies were resolved by consensus. Lesions were charac-
terized on the basis of pre-contrast visualization of the lesion,
wash-in and wash-out at semi-quantitative analysis, and pat-
tern of contrast-enhancement.
Signal intensity with respect to normal testicular parenchy-
ma on T2-weighted images (T2-WI) (markedly hypointense,
slightly hypointense, isointense and slightly hyperintense),
signal intensity on phase T1-weighted images (T1-WI)
(hypointense, isointense, slightly hyperintense), and margins
of the lesions (well-defined, blurred or irregular) were
evaluated.
The time-signal intensity curve (TIC) from contrast-
enhanced MRI was obtained by manually placing a region
of interest (ROI) within the lesions with care to exclude areas
of haemorrhage and necrosis and with the aid of correspond-
ing T1-WI and T2-WI; an identical ROI was placed on the
adjacent parenchyma.
According to the shape of the TICs, the wash-in pattern
was categorized as rapid or marked (enhancement peak within
1 min after agent injection), reflecting a high degree of vascu-
larisation, and weak and progressive (when the previous con-
dition did not occur).
The wash-out pattern was divided into rapid (decline
abrupt of the signal intensity), slow and delayed (progressive
decline of signal intensity), and absent (persistent or progres-
sive enhancement, with continuous increase in signal
intensity).
Contrast enhancement was classified as homogeneous,
non-homogeneous or rim enhancement.
For each patient, on T2-WI the observers subjectively
scored the degree of lesion-to-testis contrast according
to the following five-point scale: 1=signal intensity of
lesion is lower than those of surrounding normal testis;
2=signal intensity of lesion is equal to those of sur-
rounding normal testis; 3=signal intensity of lesion is
slightly higher than those of surrounding normal testis;
4=signal intensity of lesion is noticeably higher than
those of surrounding normal testis; 5=signal intensity
of lesion is markedly higher than those of surrounding
normal testis. The mean visual scores for lesion-to-testis
contrast was then calculated and compared.
Statistical analysis
Groups were compared using odds ratio (OR) confidence in-
tervals for categorical variables. The frequency distribution of
malignant and benign MRI features in the different group was
compared by using the chi-squared or Fisher’s exact test. Sub-
group analysis was performed to limit the comparison to the
largest groups of histotypes. Sensitivity, specificity and diag-
nostic accuracy of MRI findings in the assessment of benign
and malignant testicular lesions were calculated.
Interobserver agreement was analysed by means of Kappa
statistics. A positive correlation was considered to be indicat-
ed by a k value greater than 0, poor correlation by values of
0.00–0.01, low correlation by values of 0.01–0.20, moderate
correlation by values of 0.21–0.40, good correlation by values
of 0.41–0.60, substantial correlation by values of 0.61–0.80,
and almost perfect agreement by values greater than 0.81 [13].
Results
Clinical data
Of the 115 patients who presented a non-palpable testicular
lesion, 69 agreed to undergo a gadolinium-enhanced scrotal
MRI. Of these, 25 patients were excluded because they
showed no internal enhancement at MRI (6/69) or refused to
undergo surgery (19/69) and thus no definite histology was
available [2]. Therefore the final study group consisted of 44
patients (Fig. 1). The reason for referral is reported in Table 1.
Twenty-three patients had malignant tumours (20
seminomas, two embryonal carcinomas and one mixed germ
cell tumour) and 21 had benign tumours (19 Leydig cell tu-
mours and two Sertoli cell tumours). All 44 subjects
underwent enucleation followed by radical orchiectomy in
all 23 malignancies. Themalignancies tended to be larger than
benign tumours (mean diameter 0.9±0.31 cm vs. 0.6±
0.28 cm, respectively, p<0.001;Table 2). Full hormonal data
were available for 20 of the 44 patients. Of these, 34 % of the
patients had a FSH level of more than 7 mIU/mL (16.8±17.0,
normal range 1.38–9.58), 13 % had a decreased testosterone
level (4.4±1.6 ng/mL, normal range 2.8–11) and 20.5 % had
an elevated LH level (8.5±8.4 mIU/mL, normal range 1.8–
8.16). Inhibin B, SHBG, E2 and tumour markers were normal
at baseline in all 44 patients.
MRI qualitative results
Most of the histologically proven benign lesions appeared
hypointense on T2-WI compared to malignant lesions (17/
21, 81 %, vs. 8/23, 34.8 %, χ2 9.537, p=0.03). The remaining
benign lesions appeared slightly hypointense (14.3 % vs.
52.2%, χ2 7.013, p=0.011) and only in one case hyperintense
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(one case of benign vs. one case of malignant lesions, χ2
0.004, p=N.S.). Well-defined margins were observed in 14
of the 21 benign lesions (66.7 %) compared with five of the
23 malignant lesions (21.7 %) (χ2 9.031, p=0.003). Blurred
Fig. 1 STARD (Standards for
Reporting of Diagnostic
Accuracy) flow diagram of the
study [2]
Table 2 Clinical data (mean±
standard deviation) of all patients
and lesions according to the
reference diagnosis
Testicular volume (mL)
Final diagnosis N Age (y) Diameter (cm) R L
All patients 44 34.45±8.97 0.8±0.34 12.6±5.05 12.6±5.93
Malignant tumours 23 33.96±5.13 0.9±0.31* 12.9±5.43 12.6±5.68
Pure seminoma 20 33.57±5.84 1.0±0.32 10.50±4.65 12.32±6.29
Embryonal carcinoma 2 29±4.24 1.2±0.28 19.2±3.18 13.7±2.61
Mixed germ cell tumour 1 38 1.0 19.5 5.4
Benign tumours 21 35±11.98 0.6±0.28 12.3±4.89 12.6±6.30
Leydig cell tumour 19 36.0±13.91 0.6±0.26 12.9±4.95 13.7±6.32
Sertoli cell tumouur 2 32.6±5.50 0.4 11.9±2.96 9.7±3.25
* p<0.001 malignant tumours vs. benign tumours
R right testis, L left testis
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margins were more typical of malignant lesions (14/23, 61 %
vs. 5/21, 23.8, χ2 6.145, p=0.013).
A homogeneous enhancement was observed predominant-
ly in benign lesions (18/21, 85.7 % vs. 7/23, 30.4 %, χ2
13.672, p<0.001), whereas rim enhancement was present on-
ly in malignant tumours (4/23 vs. 0/21, χ2 4.017, p=0.109).
MRI semi-quantitative results
Benign lesions (Fig. 2) had a more rapid and intense wash-in
(18/21, 85.7 %, vs. 5/23, 21.7 %, χ2 18.008, p <0.001) and a
prolonged wash-out (15/21, 71.4 % vs. 0/23, χ2 24.926, p<
0.001), whereas malignant tumours (Figs. 3 and 4) showed a
weak and progressive wash-in (18/23, 78.3 % vs. 3/21, χ2
18.008, p<0.001) and an absent wash-out (21/23, 91.3 % vs.
6/21, 28.6 %, χ2 18.221, p<0.001) (Tables 3 and 4). Sub-
group comparisons of MRI features were also performed for
the two most numerically representative histotypes: Leydig
cell tumours (LCTs, 19 cases) and seminomas (20 cases).
The results are summarized in Tables 3 and 4.
Comparison between MRI and histology
MRI findings led to a correct pre-operative characterization in
86 % of tumours (39 of 44 cases): 17/21 of the benign and 22/
23 of the malignant tumours. Of 18 lesions (41 %, 18/44)
diagnosed as benign at MRI, 17 were found to be benign
and one malignant at final histology. Of the 26 lesions
(59 %, 26/44) initially diagnosed as malignant at MRI, 22
were confirmed while four lesions turned out to be benign at
final histology.
The sensitivity of scrotal MRI in diagnosing Leydig cell
tumour was 89.47 % (95 % CI: 66.82– 98.39), and the spec-
ificity 95.65 % (95 % CI: 77.98–99.27, Table 5).
The sensitivity of scrotal MRI in diagnosing malignant
lesions was 95.65 % (95 % CI: 77.98–99.27), and the speci-
ficity 80.95 % (95 % CI: 58.08–94.44). The diagnostic accu-
racy was 93 %.
The Kappa value for the interobserver agreement obtained
from the qualitative analysis was 0.854 (p<0.001, CI 95 %),
characterizing a very good agreement between observers.
Discussion
Our study prospectively evaluated the accuracy of qualitative
and semi-quantitative contrast-enhanced MRI in the differen-
tial diagnosis of non-palpable testicular masses. For the first
time, we described that in a large prospective series of pa-
tients, Leydig cell tumour of the testis presents distinct MRI
features that enable an accurate pre-operative diagnosis in
93 % of the cases. Furthermore, our study provides a qualita-
tive and semi-quantitative analytical description of gadolini-
um contrast kinetics in benign and malignant tumours, dem-
onstrating typical features of Leydig cell tumours and further
improving the differential diagnosis with seminomas.
US is considered the gold standard in the evaluation of
scrotal pathology. Occasionally, during a routine US exami-
nation performed for other reasons, non-palpable testicular
Fig. 2 Leydig cell tumour in the medium part of the left testes in a 38-
year-old man. T2 WI on the sagittal (a) and axial (b) planes: the lesion is
well defined and markedly hypointense. Isointense on T1 WI (c). VIBE
(volumetric interpolated breath-hold examination) subtracted T1WI after
contrast administration (d, e, f) shows a rapid and marked wash-in. The
intensity-time curve (g) shows a peak within the first minute. Histological
examination of the lesion (10x) with homogeneous tumour cells arranged
in a row is shown in (h)
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lesions are identified; among these, approximately 10 % are
tumours, half of which are malignant [14–16].
US is able to identify a scrotal mass and to differentiate its
origin (intra- or extratesticular) with a sensitivity range be-
tween 98 % and 100 % [17–19]. However, this imaging mo-
dality is considered insufficient in discriminating benign and
malignant testicular neoplasms due to their frequent overlying
appearance, particularly in case of smallest lesions.
Isidori et al. demonstrated that in experienced centres,
CEUS can improve the diagnostic accuracy of unenhanced
US in the differential diagnosis of testicular non-palpable le-
sions [2, 20, 21]. Similarly, the possibility of using MRI as the
third level imaging in the study of testicular masses has been
investigated, in particular if they are of difficult characteriza-
tion [22].
Cramer et al. [23] demonstrated the value of MRI in the
detection of testicular tumours; moreover, Adham et al. [24]
found that it may be helpful in the histological characterization
of testicular tumours. In addition, Schultz-Lampel et al. [25],
evaluating 88 patients with clinical suspicion of testicular
Fig. 3 Seminomatous lesion in the superior part of the left testes of a 35-
year-old man. T2 WI on the sagittal (a) and axial (b) planes: the lesion
appears slightly hypointense and with feathered margins. T1 WI on the
axial plane shows a weak hyperintensity of the lesion (c). VIBE
(volumetric interpolated breath-hold examination) subtracted T1 WI
shows a weak and progressive enhancement (d, e, f), which is well
visible on the intensity-time curve (g). Histological examination (10x):
the neoplasm contains abundant infiltration of lymphocytes (f)
Fig. 4 Embryo cancer on the right testes of a 30-year-old man. (a, b, c)
T2 WI. On a different axial plane, the lesion is non-homogeneous with a
hypo-isointense rounded area. Four consecutive scans of post-contrast
VIBE (volumetric interpolated breath-hold examination) sequences (e,
f, g, h) show the weak contrast enhancement only seen on the peripheral
margin. Histological examination (10x) with atypical cells and necrotic
areas (i)
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cancer, reported thatMRI was able to correctly characterize all
cases, both malignant and benign, with the limitation, in that
particular series, that nearly all benign lesions were attribut-
able to paratesticular masses.
Tsili et al. [26] highlighted the parameters that mostly ori-
ented towards characterization such as margins, signal inten-
sity of T2-WI and, in a less significant way, of T1-WI, espe-
cially for lesions that are not definable as seminomas.
Table 3 Frequencies of qualitative features MRI. Data are presented as percentages (number)
Modality Feature Benign tumour
N=21
Malignant tumour
N=23
p-value Leydig cell tumour
N=19
Seminomas
N=20
p
MRI T2-W Markedly hypointense 81 (17) 34.8 (8) 0.003 89.4 (17) 35 (7) 0.002
Slightly hypointense 14.3 (3) 52.2 (12) 0.012 5.3 (1) 60 (12) 0.003
Hyperintense 4.8 (1) 4.3 (1) 0.948 5.3 (1) 5.0 (1) 0.055
Isointense 0 (0) 8.7 (2) / / / /
T1-W Slightly hyperintense 23.8 (5) 56.5 (13) 0.032 26.3 (5) 60 (12) 0.038
Isointense 76.2 (16) 43.5 (10) 0.032 73.7 (14) 40 (8) 0.038
Margins Well defined 66.7 (14) 21.7 (5) 0.004 68.4 (13) 10 (2) 0.001
Blurred 23.8 (5) 60.9 (14) 0.016 26.3 (5) 70 (14) 0.009
Irregular 9.5 (2) 17.4 (4) 0.454 5.3 (1) 20 (4) 0.198
DCE-MRI Enhancement Homogeneous 85.7 (18) 30.4 (7) 0.001 94.7 (18) 30 (6) 0.001
Non-homogeneous 14.3 (3) 52.2 (12) 0.012 5.3 (1) 60 (12) 0.003
Rim enhancement 0 (0) 17.4 (4) / 0 (0) 10 (2) /
Wash-in Rapid and intense 85.7 (18) 21.7 (5) <0.001 94.7 (18) 15 (3) <0.001
Weak and progressive 14.3 (3) 78.3 (18) <0.001 5.3 (1) 85 (17) <0.001
Wash-out Slow and delayed 71.4 (15) 0 (0) / 78.9 (15) 0 (0) /
Rapid 0 (0) 8.7 (2) / 0 (0) 10 (2) /
Absent 28.6 (6) 91.3 (21) <0.001 21.1 (4) 90 (18) <0.001
Table 4 Diagnostic performance of MRI in the differential diagnosis of testicular lesions
Modality Feature Benign vs. malignant tumours LCTs vs. seminomas
χ2 p-value χ2
MRI T2-W Markedly hypointense 9.537 0.003a 12.216 0.001a
Slightly hypointense 7.013 0.011a 13.137 <0.001a
Hyperintense 0.004 1.000a 0.001 1.000a
Isointense 1.913 0.489a / /
T1-W Slightly hyperintense 4.859 0.027 4.496 0.034
Isointense 4.859 0.027 4.496 0.034
Margins Well defined 9.031 0.003 14.050 <0.001a
Blurred 6.145 0.013 7.442 0.006
Irregular 0.577 0.666 1.893 0.342a
DCE-MRI Enhancement Homogeneous 13.672 <0.001 17.252 <0.001
Non-homogeneous 7.013 0.011 13.137 <0.001a
Rim enhancement 4.017 0.109 2.003 0.487a
Wash-in Rapid and intense 18.008 <0.001 24.927 <0.001
Weak and progressive 18.008 <0.001 24.927 <0.001
Wash-out Slow and delayed 24.926 <0.001 25.658 <0.001a
Rapid 1.913 0.489 2.003 0.487a
Absent 18.221 <0.001 18.837 <0.001a
a Fisher exact test
LCTs Leydig cell tumours
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Diffusion-weighted imaging (DWI) and apparent diffusion
coefficient (ADC) values are potentially valuable in the dif-
ferentiation between normal, benign and malignant scrotal
lesions, allowing complementary information for morpholog-
ical and contrast-enhanced imaging. Qualitative evaluation of
DWI may also be helpful, even if the quantitative ADC values
are not useful.
According to others [27, 28], in our experience the
wide individual variation of ADC measurements and the
difficulty in suggesting the ADC cut-off value as an
effective parameter for tissue characterization limited
the use of DWI in the evaluation of testicular lesions.
Our data confirm that a markedly hypointense signal on
T2-WI is significantly associated with a benign nature
of the lesion, and this feature may be suggestive of a
Leydig cell tumour (80 % of all benign and 90 % of
Leydig cell tumours included in our series). Further-
more, a typical pattern of contrast enhancement, charac-
terized by homogeneous impregnation (p=0.001) and
rapid and marked wash-in (p<0.001), was found in
94.7 % of Leydig cell tumours, accompanied by a slow
and late wash-out (p<0.001). This behaviour, with the
appropriate distinction, is similar to what was observed
in contrast-enhanced US [2], and has been attributed to
a high degree of vascularization of Leydig cell tumours,
local estrogen generation and an increased level of
endocrine-gland vascular endothelial growth factor
(EG-VEGF) expressed by Leydig cells [29–31]. Malig-
nant lesions were significantly associated with blurred
margins (p=0.013) and a weak hypointense signal on
T2-WI (p=0.011). Seminomas showed this feature in
70 % (p=0.009) and 60 % (p=0.003) of the cases,
respectively. Another feature found in this study is rep-
resented by a weak signal hyperintensity on T1 in 60 %
of cases of seminoma (p = 0.038). Furthermore,
seminomatous lesions showed weak and progressive
wash-in (p<0.001) in 85 % of cases, with an absent
wash-out (p<0.001). Our pattern differs from those re-
ported in other studies in which seminomas are charac-
terized by an enhancement with a rapid increase of sig-
nal intensity followed by gradual washout of the con-
trast medium [12]. The Sertoli cell tumours in our series
showed a DCE-MRI behaviour similar to seminomas,
and therefore were erroneously considered malignancies.
Because of their rarity, a conclusive statement cannot be
made; however, recent data suggest that Sertoli cell tu-
mours do not express EG-VEGF to the high level seen
in LCTs [29]. An important finding of this study was
the very high frequency of Leydig cell tumours. This
supports the hypothesis that Leydig cell dysfunction
has a role in testicular dysgenesis syndrome [28] and
it is sustained by the finding of subclinical hormonal
failure (high LH or reduced testosterone) found in
20.5 % and 13 % of our patients, respectively [32].
Our study has some limitations: first, our series in-
cluded patients with small (<1.5 cm) non-palpable le-
sions evaluated by CEUS in a previous study [2], which
already, and independently of MRI findings, improved
the differential diagnosis and the individualized manage-
ment of small testicular lesions. Despite these results,
MRI was performed blinded to CEUS results to evalu-
ate prospectively the accuracy of qualitative and semi-
quantitative contrast-enhanced MRI in the differential
diagnosis of non-palpable testicular masses. Secondly,
the semi-quantitative analysis, which depends on the
placement of the ROI, could be affected by the small
size of the tumour. Third, we can’t ignore that the case
mix may have affected the sensitivity (one false-
negative case) and the specificity (four false-positive
cases) of MRI. We considered four benign tumours to
be malignant (two Sertoli cell tumours and two LCTs)
because they showed two features that we attributed to
malignant neoplasms: weak and progressive wash-in, ab-
sent wash-out and a slight hypointense signal on T2-
weighted images. Nevertheless, to our knowledge the
present series is the largest prospective collection of
MRI imaging of Leydig cell tumours. The only false-
negative case of the study (one embryonal carcinoma)
was misdiagnosed because of its well-defined margins
and rim enhancement, which had made radiologists lean
towards the nature of an active inflammation, supported
by the clinical history of the patient who reported fever,
elevated white cell count, pain in the scrotal region and
negative markers. In our sample, both cases of embry-
onal carcinomas showed a pattern of rim enhancement,
requiring a differential diagnosis toward inflammatory
lesions. Even if this feature cannot be standardized, it
may find an explanation in the aggressive nature of this
tumour, which is often characterized by areas of haem-
orrhage and necrosis, producing a central non-enhancing
Table 5 Diagnostic performance
of MRI in diagnosing Leydig cell
tumour
Diagnostic performance of MRI, % (95 %CI)
Diagnosing Leydig cell tumours Diagnosing malignant lesions
Sensitivity 89.47 (66.82–98.39) 95.65 (77.98–99.27)
Specificity 95.65 (77.98–99.27) 80.95 (58.08–94.44)
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area; moreover, in agreement with our data [33, 34],
even at CEUS, embryonal carcinomas were character-
ized by poor or absent internal contrast enhancement
[15].
In conclusion, the results achieved with our protocol (fur-
ther improvements can be obtained by use of specified perfu-
sion sequences and 3D high resolution T2 sequences), dem-
onstrated that MRI might be proposed in addition to
unenhanced US and CEUS when it is necessary to decide
the best therapeutic procedure for a testicular mass not yet
characterized. Our study demonstrated that MRI is able not
only to characterize benign and malignant testicular lesions,
with a diagnostic accuracy of 93 %, but also suggests a spe-
cific diagnostic hypothesis when specific imaging features are
present. Well-defined margins, a markedly hypointense signal
on T2-WI, and a rapid andmarkedwash-in followed by a slow
and late wash-out, should orient toward the diagnosis of
Leydig cell tumour. On the other hand, blurred margins, a
slightly hypointense signal on T2-WI and a slightly hyperin-
tense signal on T1-WI, associated with a weak and progres-
sive wash-in followed by an absent wash-out, are highly spe-
cific for the diagnosis of seminoma.
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